Table 3

Univariate and multivariate analysis for OS

UnivariateMultivariate
HR95% CIPHR95% CIP
CR1 duration* .94 .89-.98 .005 .88 .81-.94 <.001 
GO .48 .26-.88 .02 .38 .16-.87 .02 
AlloSCT .55 .32-0.94 .03 .64 .32-1.28 .21 
Age*† 1.22 1.02-1.46 .03 1.26 .94-1.71 .13 
CBFB vs CBFA .76 .46-1.26 .28 .32 .16-.66 .002 
Primary trial       
 ALFA-9801 as baseline       
  ALFA-9802 .71 .31-1.65 .43 .39 .10-1.45 .16 
  LAM-2001 .99 .50-1.97 .98 1.34 .48-3.72 .58 
  CBF-2006 .45 .21-.99 .05 1.28 .29-5.74 .74 
UnivariateMultivariate
HR95% CIPHR95% CIP
CR1 duration* .94 .89-.98 .005 .88 .81-.94 <.001 
GO .48 .26-.88 .02 .38 .16-.87 .02 
AlloSCT .55 .32-0.94 .03 .64 .32-1.28 .21 
Age*† 1.22 1.02-1.46 .03 1.26 .94-1.71 .13 
CBFB vs CBFA .76 .46-1.26 .28 .32 .16-.66 .002 
Primary trial       
 ALFA-9801 as baseline       
  ALFA-9802 .71 .31-1.65 .43 .39 .10-1.45 .16 
  LAM-2001 .99 .50-1.97 .98 1.34 .48-3.72 .58 
  CBF-2006 .45 .21-.99 .05 1.28 .29-5.74 .74 
*

Continuous variable.

†

HR for a 10-year increment.

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal